Browsing: News & updates

Anavex Life Sciences (AVXL), a key player in biopharmaceuticals, is grappling with manufacturing challenges that threaten its product launch and financial stability. The company recently announced complications in its manufacturing processes, causing concern among investors and stakeholders. Risks in…